SUNRISE-CRC: a randomized phase II study of high-dose intermittent sunitinib versus trifluridine/tipiracil in metastatic colorectal carcinoma
Sophie L. Gerritse, Marianne A. Jonker, Elske C. Gootjes, Miriam L. Wumkes et al.
Journal
The Oncologist
Topics
Colorectal Cancer Treatments and Studies
article
SUNRISE-CRC: a randomized phase II study of high-dose intermittent sunitinib versus trifluridine/tipiracil in metastatic colorectal carcinoma
Sophie L. Gerritse, Marianne A. Jonker, Elske C. Gootjes, Miriam L. Wumkes, Mariëtte Labots, Joeri A J Douma, Laurien M. Buffart, Jan Paul Medema, Nielka P. van Erp, Jorien B.E. Janssen, Tineke E. Buffart, Dennis Poel, Daniele V. F. Tauriello, Eline Janssen, Erik van den Hombergh, Henk M.W. Verheul, Kirti K. Iyer, Mirte Mayke Streppel
article en
Abstract
No abstract available for this paper.
Publication Tag
The OncologistVol. 30(10)
Institutions
Radboud University Nijmegen (NL), Dutch Cancer Society (NL), Radboud University Medical Center (NL), Amphia Ziekenhuis (NL), Amsterdam Neuroscience (NL), Oncode Institute (NL), Erasmus MC Cancer Institute (NL), Jeroen Bosch Ziekenhuis (NL), Vrije Universiteit Amsterdam (NL), University of Amsterdam (NL)